- Home
- PBFS vs XOMA Comparison
PBFS vs XOMA Comparison
Compare PBFS & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBFS
- XOMA
- Stock Information
- Founded
- PBFS 1889
- XOMA 1981
- Country
- PBFS United States
- XOMA United States
- Employees
- PBFS N/A
- XOMA N/A
- Industry
- PBFS Banks
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- PBFS Finance
- XOMA Health Care
- Exchange
- PBFS Nasdaq
- XOMA Nasdaq
- Market Cap
- PBFS 287.0M
- XOMA 300.5M
- IPO Year
- PBFS N/A
- XOMA N/A
- Fundamental
- Price
- PBFS $11.58
- XOMA $24.05
- Analyst Decision
- PBFS
- XOMA Strong Buy
- Analyst Count
- PBFS 0
- XOMA 2
- Target Price
- PBFS N/A
- XOMA $69.50
- AVG Volume (30 Days)
- PBFS 28.6K
- XOMA 40.4K
- Earning Date
- PBFS 05-09-2025
- XOMA 08-12-2025
- Dividend Yield
- PBFS N/A
- XOMA N/A
- EPS Growth
- PBFS 27.31
- XOMA N/A
- EPS
- PBFS 0.80
- XOMA N/A
- Revenue
- PBFS $88,641,000.00
- XOMA $42,909,000.00
- Revenue This Year
- PBFS N/A
- XOMA $70.91
- Revenue Next Year
- PBFS N/A
- XOMA $14.00
- P/E Ratio
- PBFS $14.25
- XOMA N/A
- Revenue Growth
- PBFS 21.19
- XOMA 638.41
- 52 Week Low
- PBFS $9.56
- XOMA $18.35
- 52 Week High
- PBFS $12.20
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- PBFS 54.76
- XOMA 45.38
- Support Level
- PBFS $11.41
- XOMA $23.51
- Resistance Level
- PBFS $11.69
- XOMA $24.65
- Average True Range (ATR)
- PBFS 0.18
- XOMA 1.10
- MACD
- PBFS 0.01
- XOMA -0.17
- Stochastic Oscillator
- PBFS 84.44
- XOMA 20.92
About PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.